Case Report of a Juvenile Patient with Autism Spectrum Disorder with a Novel Combination of Copy Number Variants in ADGRL3 (LPHN3) and Two Pseudogenes.

The Application of Clinical Genetics Pub Date : 2022-09-02 eCollection Date: 2022-01-01 DOI:10.2147/TACG.S361239
Martin H Maurer, Anja Kohler, Melanie Hudemann, Jerome Jüngling, Saskia Biskup, Martin Menzel
{"title":"Case Report of a Juvenile Patient with Autism Spectrum Disorder with a Novel Combination of Copy Number Variants in <i>ADGRL3</i> (<i>LPHN3</i>) and Two Pseudogenes.","authors":"Martin H Maurer,&nbsp;Anja Kohler,&nbsp;Melanie Hudemann,&nbsp;Jerome Jüngling,&nbsp;Saskia Biskup,&nbsp;Martin Menzel","doi":"10.2147/TACG.S361239","DOIUrl":null,"url":null,"abstract":"<p><p>We report the finding of two copy number variants (CNVs) in a 12-year-old boy presenting both with autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD). Clinical features included aggressive behavior, mood instability, suicidal statements, repetitive and restrictive behavior, sensitivity to noise, learning problems and dyslexia, though no intellectual disability was present. Using array-based comparative genomic hybridization (array-CGH), we identified two CNVs, both triplex duplications of 324 kb on 3p26.3, and 284 kb on 4q13.1, respectively. One of the CNVs is located on chromosome 4q13.1 in the region of the gene encoding for adhesion G protein-coupled receptor L3 (<i>ADGRL3</i>, former name: latrophilin-3, <i>LPHN3</i>), the other on chromosome 3p26.3 in the region of the two pseudogenes <i>AC090043.1</i> and <i>RPL23AP39</i>. The patient described in the present study showed increased symptoms under methylphenidate treatment but responded positively to 3 mg per day of the atypical neuroleptic drug aripiprazole. To our knowledge, this is the first report of a CNV in the <i>ADGRL3</i> gene and its first association with ASD in humans.</p>","PeriodicalId":506374,"journal":{"name":"The Application of Clinical Genetics","volume":" ","pages":"125-131"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/d2/tacg-15-125.PMC9447451.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Application of Clinical Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/TACG.S361239","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We report the finding of two copy number variants (CNVs) in a 12-year-old boy presenting both with autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD). Clinical features included aggressive behavior, mood instability, suicidal statements, repetitive and restrictive behavior, sensitivity to noise, learning problems and dyslexia, though no intellectual disability was present. Using array-based comparative genomic hybridization (array-CGH), we identified two CNVs, both triplex duplications of 324 kb on 3p26.3, and 284 kb on 4q13.1, respectively. One of the CNVs is located on chromosome 4q13.1 in the region of the gene encoding for adhesion G protein-coupled receptor L3 (ADGRL3, former name: latrophilin-3, LPHN3), the other on chromosome 3p26.3 in the region of the two pseudogenes AC090043.1 and RPL23AP39. The patient described in the present study showed increased symptoms under methylphenidate treatment but responded positively to 3 mg per day of the atypical neuroleptic drug aripiprazole. To our knowledge, this is the first report of a CNV in the ADGRL3 gene and its first association with ASD in humans.

Abstract Image

ADGRL3 (LPHN3)拷贝数变异与两个假基因新组合的青少年自闭症谱系障碍病例报告
我们报告在一名患有自闭症谱系障碍(ASD)和注意缺陷/多动障碍(ADHD)的12岁男孩中发现两个拷贝数变异(CNVs)。临床特征包括攻击性行为、情绪不稳定、自杀陈述、重复性和限制性行为、对噪音敏感、学习问题和阅读障碍,尽管没有智力残疾。使用基于阵列的比较基因组杂交(array-CGH),我们鉴定了两个CNVs,它们都是3p26.3上的324 kb的三重重复,4q13.1上的284 kb。其中一个CNVs位于染色体4q13.1上粘附G蛋白偶联受体L3 (ADGRL3,原名:latrophilin-3, LPHN3)基因编码区域,另一个位于染色体3p26.3上两个假基因AC090043.1和RPL23AP39的区域。本研究中描述的患者在哌甲酯治疗下症状加重,但对非典型抗精神病药物阿立哌唑每天3mg有积极反应。据我们所知,这是ADGRL3基因CNV的首次报道,也是其与人类ASD的首次关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书